These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36633607)

  • 1. [Attention deficit hyperactivity disorder and substance use in adulthood-Guideline-conform diagnostics and treatment].
    Kölle M; Philipsen A; Mackert S
    Nervenarzt; 2023 Jan; 94(1):47-57. PubMed ID: 36633607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions.
    Fatséas M; Hurmic H; Serre F; Debrabant R; Daulouède JP; Denis C; Auriacombe M
    Psychiatry Res; 2016 Dec; 246():656-662. PubMed ID: 27842945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].
    Fallgatter AJ; Jacob CP
    Nervenarzt; 2009 Sep; 80(9):1015-21. PubMed ID: 19672572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions].
    Matthys F; Joostens P; van den Brink W; Sabbe B
    Ned Tijdschr Geneeskd; 2013; 157(24):A6025. PubMed ID: 23759179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder (ADHD) and substance use disorders.
    Wilson JJ; Levin FR
    Curr Psychiatry Rep; 2001 Dec; 3(6):497-506. PubMed ID: 11707164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
    Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
    Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy].
    Dirks H; Scherbaum N; Kis B; Mette C
    Fortschr Neurol Psychiatr; 2017 Jun; 85(6):336-344. PubMed ID: 28645126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult ADHD and substance abuse: diagnostic and treatment issues.
    Kalbag AS; Levin FR
    Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance Use Disorder in Adults with ADHD in South Dakota.
    McMahon C
    S D Med; 2023 Sep; 76(9):398. PubMed ID: 37738488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention deficit hyperactivity disorder (ADHD) and addiction].
    Hässler F; Reis O
    MMW Fortschr Med; 2010 May; 152(18):46-8. PubMed ID: 20514764
    [No Abstract]   [Full Text] [Related]  

  • 15. [ADHD and addiction; application of the Belgian guideline with particular reference to comorbid affective disorders].
    Matthys F; Joostens P; Tremmery S; Stes S; Sabbe B
    Tijdschr Psychiatr; 2013; 55(9):715-9. PubMed ID: 24046250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to manage adult attention deficit hyperactivity disorder in patients with substance use disorders?].
    Kebir O; Laqueille X
    Rev Prat; 2020 Mar; 70(3):293-300. PubMed ID: 32877064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impulsivity as an immediate factor between addictive disorders and Attention Deficit-Hyperactivity Disorder].
    Lazaratou H; Palaiologou A; Anagnostopoulos D
    Psychiatriki; 2017; 28(2):156-164. PubMed ID: 28686562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
    Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
    Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
    Kapitány-Fövény M; Barta C; Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Coetzee C; Luderer M; Schellekens A; Matthys F; Demetrovics Z;
    Psychiatr Hung; 2020; 35(4):435-447. PubMed ID: 33263293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.